Pancreatic Cancer Research

ResearcherSecond Military Medical UniversityNo recent work listed

Kun Lin

ORCID-verified (high confidence, 0.95), identity_conf@1As of 9 November 2026

Matched on ORCID iD 0000-0002-8572-9479; OpenAlex author ID A5102905658. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: 1 paper

Papers 2

  1. Silencing GS Homeobox 2 Alleviates Gemcitabine Resistance in Pancreatic Cancer Cells by Activating SHH/GLI1 Signaling Pathway. Last author DOI 10.1007/s10620-021-07262-1↗
  2. HPP1 gene promoter methylation in pancreatic cancer: correlation with carcinogenesis and clinical implication. Co-author PMID 31949740↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Lu Zhuang · 2 shared papers, 2018–2022 · strength 0.24
  2. Yang Zhang · 2 shared papers, 2018–2022 · strength 0.24
  3. Lisi Peng · 2 shared papers, 2018–2022 · strength 0.24
  4. Zhaoshen Li · 1 shared paper, 2018 · strength 0.08
  5. Kaixuan Wang · 1 shared paper, 2018 · strength 0.08
  6. Haojie Huang · 1 shared paper, 2018 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.